Indoco Remedies Share Price Live
Live Indoco Remedies Share Price Chart
Indoco Remedies Performance
Days Range
| Previous Close | ₹257.25 |
|---|---|
| Open | ₹252.1 |
| Volume | 60,210 |
| Day's Range | ₹251.70 - ₹255.40 |
|---|---|
| 52W Range | ₹190.00 - ₹355.00 |
| Market Cap | ₹2,382.30 Cr |
Indoco Remedies Fundamentals
| ROCE(TTM) | -2.11 |
|---|---|
| P/E Ratio (TTM) | -20.66 |
| P/B Ratio | 2.43 |
| Industry P/E | 33.01 |
| Debt to Equity | 1.02 |
| ROE | -11.28 |
| EPS (TTM) | 0 |
| Dividend Yield | 0.08 |
| Book Value | 106.21 |
| Face Value | 2 |
| ROCE(TTM) | -2.11 |
|---|---|
| P/E Ratio (TTM) | -20.66 |
| P/B Ratio | 2.43 |
| Industry P/E | 33.01 |
| Debt to Equity | 1.02 |
| ROE | -11.28 |
|---|---|
| EPS (TTM) | 0 |
| Dividend Yield | 0.08 |
| Book Value | 106.21 |
| Face Value | 2 |
Indoco Remedies Financials
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | |
|---|---|---|---|---|
| Net Sales | 402.45 | 383.89 | 430.86 | 471.83 |
| Expenses | 427.24 | 419.77 | 451.84 | 473.87 |
| Profit before tax | -30.96 | -45.52 | -36.66 | -13.53 |
| Operating Profit | -28.40 | -41.34 | -36.35 | -9.21 |
| Net Profit | -28.40 | -41.34 | -36.35 | -9.21 |
| ESP in Rs | -3.19 | -4.48 | -3.94 | -0.94 |
Indoco Remedies Shareholding Pattern
| Held by | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|
| Promoters | 58.75% | 58.8% | 58.9% | 58.9% | 58.9% |
| Flls | 1.7% | 1.25% | 1.24% | 1.22% | 1.25% |
| Dlls | 18.24% | 18.9% | 18.75% | 18.96% | 18.16% |
| Public | 21.31% | 21.06% | 21.11% | 20.92% | 21.69% |
About Indoco Remedies
Indoco Remedies (Indoco) is a Mumbai-based pharmaceutical company that focuses on formulations, with some presence in contract manufacturing and research. It also trades some active pharma ingredients (APIs) manufactured by a group company.
Currently, Indoco has a presence in the therapeutic segments including anti-infective, anti-cold preparation, opthalmic, anti-spasmodic, stomatology, anti-inflammatory and anti-fungal. As per AC Nielsen ORG-MARG market survey (August 2004) of doctors, Indoco ranked first in the stomatology, ninth in the opthalmic and twelve in the pediatric segments in terms of prescription generation in the domestic market. In the overall pharma industry, Indoco is ranked 34th as per AC Nielsen ORG-MARG Retail Audit, but ranked 23rd in terms of prescription generation, indicating the strength of its marketing network. Further, the company last year launched a new super specialty division, with focus on diabetic and cardio-vascular segments. Its entry into the lifestyle segment with a strong presence in the prescription segment would augur well for the higher- than-average industry growth.
Currently, Indoco has four manufacturing facilities. Two are located in Mumbai and two in Goa, and an R&D centre in Mumbai. The solid dosage facility in Goa has been accredited by UK-Medicines and Healthcare Products Regulatory Agency (MHRA), and the sterile plant of Goa has been designed as per US Food and Drug Administration (FDA) norms. On the selling front, it has a marketing network of 1,248 medical representatives.
Parent Organisation
Indian Private
Managing Director
Suresh G Kare
Founded
1947
NSE Symbol
INDOCO
Top Mutual Funds Invested in Indoco Remedies Share
Top Mutual Funds Invested in Indoco Remedies Share
Peer Comparison
Peer Comparison
| Stocks | LTP (₹) | Market Cap (cr) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 1,775.0 -4.70 (-0.26%) | ₹4,27,033.64 | 1,548.0 - 1,910.0![]() |
| Divis Laboratories Ltd | 6,336.5 -36.50 (-0.57%) | ₹1,69,211.00 | 4,955.0 - 7,071.5![]() |
| Torrent Pharmaceuticals Ltd | 3,729.1 42.60 (1.16%) | ₹1,24,868.91 | 2,886.45 - 3,882.2![]() |
| Cipla Ltd | 1,509.2 -2.60 (-0.17%) | ₹1,22,082.50 | 1,335.0 - 1,673.0![]() |
| Dr Reddys Laboratories Ltd | 1,233.2 -10.70 (-0.86%) | ₹1,03,872.78 | 1,020.0 - 1,405.9![]() |
| Zydus Lifesciences Ltd | 925.05 0.75 (0.08%) | ₹93,026.33 | 795.0 - 1,059.05![]() |
Popular stocks
Indoco Remedies Ltd FAQs
What is the share price of Indoco Remedies Ltd (INDOCO) shares?
Indoco Remedies Ltd (INDOCO) share price as of November 21, 2025, on NSE is Rs 257.25 (NSE) and Rs 257.25 (BSE) on BSE.
Can I buy Indoco Remedies Ltd (INDOCO) from Angel One?
Yes, You can buy Indoco Remedies Ltd (INDOCO) shares by opening a Demat account with Angel One.
How do I buy Indoco Remedies Ltd (INDOCO) from Angel One?
Indoco Remedies Ltd (INDOCO) share can be bought through the following modes:
1. Direct investment: You can buy Indoco Remedies Ltd (INDOCO) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Indoco Remedies Ltd (INDOCO) shares.
1. Direct investment: You can buy Indoco Remedies Ltd (INDOCO) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Indoco Remedies Ltd (INDOCO) shares.
What is the main business of Indoco Remedies ?
The main business of Indoco Remedies is manufacturing and marketing of Pharmaceutical formulations (i.e. finished dosages) and APIs (i.e. active pharmaceutical ingredients).
Who are the promoters of Indoco Remedies ?
Spa Holdings Pvt Ltd, Shanteri Investment Pvt Ltd, Panandikar Aditi Milind, Ramani Madhura Anup, Kare Aruna Suresh and Kare Suresh Govind are some of the major promoters of Indoco Remedies.
What are the Subsidiaries that comes under Indoco Remedies ?
As on March 31, 2022, the company has three subsidiary companies which are Xtend Industrial Designers and Engineers Private Limited, Indoco Remedies Czech SRO and Indoco Remedies UK. Limited.




